AKT1 and cancer: Because AKT is known as a central converging node for many oncogenic upstream kinases 14 and confers resistance to many cancer therapeutics 15, we determined the effects of combining PI-103, a PI3K/AKTi, with several EGFRis in TNBC cell lines.